Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT01069705
Status:
COMPLETED
Last Update Posted:
2021-06-02
First Post:
2010-02-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Second Open Label Extension to Bridging Study CTBM100C2303
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2012-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2010-02-15
First Submit QC Date:
None
Study First Post Date:
2010-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-05-06
Results First Submit QC Date:
None
Results First Post Date:
2021-06-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-06
Last Update Post Date:
2021-06-02
Last Update Post Date Type:
ACTUAL